Policy · 117th Congress
House report questions FDA’s approval of Alzheimer’s drug
A decision on accelerated approval is due by Jan. 6, and the company is simultaneously submitting data for full approval based on results from a Phase 3 trial.
Search Roll Call
Search the Roll Call archive by keyword, date, Congress, section, or tags.
14 results for "6"
Campaigns · 117th Congress
Abortion rights backers see big wins in Tuesday results
Opponents spent nearly $23 million against the initiative; advocates spent more than $6 million.
Policy · 117th Congress
Biden ponders marijuana moves as states forge ahead
The Biden administration’s Oct. 6 announcement that it would revisit that classification comes after previous, yearslong reviews of marijuana’s categorization fell flat, and experts are split on
Congress · 117th Congress
Stopgap funding bill set to dominate September agenda
It also may not be clear what the outcome of Senate control will be until after Dec. 6 if the Georgia race goes to a runoff, which could leave little time for a burst of legislative action before lawmakers
Policy · 117th Congress
FDA panel gives green light to pediatric COVID-19 vaccines
The Pfizer shot, for children 6 months to 4 years old, is a three-dose vaccine with three micrograms per dose.
Policy · 117th Congress
Moderna asks FDA to authorize COVID-19 vaccine for kids under 6
Moderna said Thursday that it asked the Food and Drug Administration for emergency use authorization of its COVID-19 vaccine in kids under age 6, making it the first drug company to do so.
Campaigns · 117th Congress
Michigan Rep. Fred Upton announces plan to retire
Upton was among the Republican House members who voted in favor of impeaching President Donald Trump after the Jan. 6, 2021, insurrection at the Capitol.
Policy · 117th Congress
Patients’ groups, progressives square off over Medicare Alzheimer’s decision
Patient groups, many of which have close ties to drugmakers developing treatments, say the move will block most of the country’s 6 million Alzheimer’s patients from a potential opportunity to slow
Policy · 117th Congress
FDA seeks more data before reviewing COVID-19 vaccine for toddlers
The FDA had planned to meet on Feb. 15 to review a two-dose regimen of the Pfizer shots for young children ages 6 months to 4 years old, but officials on Friday said the agency needs more time to
Policy · 117th Congress
FDA authorizes COVID-19 vaccines for younger kids
The FDA has been independently verifying the data supporting the safety and efficacy of the kid-sized doses, in addition to data showing they are necessary, since Oct. 6.
Policy · 117th Congress
CDC advisers back third COVID-19 shot for older and high-risk people
Members voted, 9-6, for those who are 18 to 49 with underlying conditions.
Policy · 117th Congress
Medicare demo emerges as coverage option for Alzheimer’s drug
Alzheimer’s afflicts more than 6 million Americans, and is the sixth-leading cause of death in the United States.
Policy · 117th Congress
White House outlines plans to donate coronavirus vaccines abroad
The other 6 million doses will go to countries that are regional priorities or partners.
Policy · 117th Congress
States react to short Johnson & Johnson COVID-19 vaccine pause
Many states reported that the Johnson & Johnson vaccine comprised just 4 to 6 percent of total vaccines supplied to the state so far, and were expecting only a trickle of doses over the next month